Doctor Paul Guedeney

Doctor Paul Guedeney

Pitie Salpetriere APHP University Hospital, Paris (France)

Member of:

2017. M.D. in Cardiology and vascular disease (Paris Sorbonne University). 2017-2018. Research scholar at the Zena and Michael A. Weiner Cardiovascular Institute, Icahn school of medicine at Mount Sinai, under the direction of Dr Roxana Mehran. 2018-Today. Interventional cardiology Fellow at the cardiology Institute, Pitié Salpêtrière Hospital, Paris, France, under the direction of Pr Montalescot.

Presentations

Respective impact of bleeding and ischemic complications of mortality after percutaneous coronary interventions: substudy from the FRANCE-PCI registry

Event: ESC Congress 2024

Topic: Percutaneous Coronary Intervention (PCI)

Session: The guardians of clotting: exploring antiplatelet strategies

Access

Prevalence, determinants, and impact of significant shunt after percutaneous patent foramen ovale closure

Event: ESC Congress 2024

Topic: Patent Foramen Ovale (PFO) / Atrial Septal Defect (ASD) Closure

Session: Advances in left atrial appendage and patent foramen ovale closure

Access

Venous thrombo-embolic events as the probable cause of arterial ischemic event in patients with patent foramen ovale

Event: ESC Congress 2024

Topic: Patent Foramen Ovale (PFO) / Atrial Septal Defect (ASD) Closure

Session: Advances in left atrial appendage and patent foramen ovale closure

Access

Role of inflammation and cholesterol efflux in myocardial infarction patients without standard modifiable risk factors

Event: ESC Congress 2024

Topic: Inflammation and Immunity

Session: Pathophysiology of coronary artery disease: new insights

Access

Impact of the antiplatelet strategy following patent foramen ovale percutaneous closure

Event: ESC Congress 2023

Topic: Patent Foramen Ovale (PFO) / Atrial Septal Defect (ASD) Closure

Session: Young Investigator Awards Session in Thrombosis

Access

Outcomes following patent foramen ovale percutaneous closure according to the delay from last ischemic event

Event: ESC Congress 2022

Topic: Patent Foramen Ovale (PFO) / Atrial Septal Defect (ASD) Closure

Session: Patent foramen ovale closure and left atrial appendage closure

Access

Supraventricular arrhythmia following patent foramen ovale percutaneous closure

Event: ESC Congress 2022

Topic: Patent Foramen Ovale (PFO) / Atrial Septal Defect (ASD) Closure

Session: Patent foramen ovale closure and left atrial appendage closure

Access

Comparison of the safety and efficacy of antithrombotic regimens following TAVR in patients without having an indication for chronic oral anticoagulation

Event: ESC Congress 2022

Topic: Aortic Valve Intervention

Session: Transcatheter aortic valve implantation: trends, outcomes, and procedural considerations

Access

Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis - report from an international registry

Event: ESC Congress 2022

Topic: Cardio-Oncology

Session: Cardio-oncology 1

Access

First clinical experience with the wearable cardiac rhythm long-term monitoring cardioskin device

Event: ESC Congress 2020

Topic: Remote Patient Monitoring and Telehealth

Session: Wearables and the ECG: What Progress Are We Making?

Access

ESC 365 is supported by

Explore sponsored resources

Doctor Paul Guedeney

Biography

Contributor content

Respective impact of bleeding and ischemic complications of mortality after percutaneous coronary interventions: substudy from the FRANCE-PCI registry

Prevalence, determinants, and impact of significant shunt after percutaneous patent foramen ovale closure

Venous thrombo-embolic events as the probable cause of arterial ischemic event in patients with patent foramen ovale

Role of inflammation and cholesterol efflux in myocardial infarction patients without standard modifiable risk factors

Impact of the antiplatelet strategy following patent foramen ovale percutaneous closure

Outcomes following patent foramen ovale percutaneous closure according to the delay from last ischemic event

Supraventricular arrhythmia following patent foramen ovale percutaneous closure

Comparison of the safety and efficacy of antithrombotic regimens following TAVR in patients without having an indication for chronic oral anticoagulation

Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis - report from an international registry

First clinical experience with the wearable cardiac rhythm long-term monitoring cardioskin device

ESC 365 is supported by

Doctor Paul Guedeney Follow

Biography

Contributor content

Respective impact of bleeding and ischemic complications of mortality after percutaneous coronary interventions: substudy from the FRANCE-PCI registry

Prevalence, determinants, and impact of significant shunt after percutaneous patent foramen ovale closure

Venous thrombo-embolic events as the probable cause of arterial ischemic event in patients with patent foramen ovale

Role of inflammation and cholesterol efflux in myocardial infarction patients without standard modifiable risk factors

Impact of the antiplatelet strategy following patent foramen ovale percutaneous closure

Outcomes following patent foramen ovale percutaneous closure according to the delay from last ischemic event

Supraventricular arrhythmia following patent foramen ovale percutaneous closure

Comparison of the safety and efficacy of antithrombotic regimens following TAVR in patients without having an indication for chronic oral anticoagulation

Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis - report from an international registry

First clinical experience with the wearable cardiac rhythm long-term monitoring cardioskin device

ESC 365 is supported by

Doctor Paul Guedeney